Insulin Syringes Market Updates

Skyquest Technology's expert advisors continuously track and analyze the latest developments and updates related to insulin syringes market. Our team of analysts stay abreast of all the recent news stories shaping the industry including new product launches by major companies, strategic partnerships, M&As, Patent filings and industry and regulatory developments.

Insulin Syringes Market News

in Insulin Syringes Market
  • In March 2024, MTD (Medical Technology and Devices) purchased Ypsomed's pen needle and blood glucose monitoring businesses. The acquisition added MTD's diabetes care product portfolio as well as consolidated its global leadership in the production of pen needles. The step is intended to enhance innovation and market share in insulin delivery solutions, further enhancing patient care solutions across the globe.
  • In June 2024, Eli Lilly reported significant progress with Efsitora, a once-weekly insulin injection. Clinical trials demonstrated that Efsitora effectively manages blood glucose levels comparable to daily insulin shots for both new and switching patients. This innovation could revolutionize diabetes treatment by reducing injection frequency and improving patient adherence to insulin therapy.
  • In June 2024, Insulet released its Omnipod 5 insulin pump system with integrated Dexcom G7 continuous glucose monitoring in the United States. The system, which is well-advanced, now automates the delivery of insulin using real-time glucose levels to better manage diabetes. Easier device pairing and improved user experience enable patients to maintain better control of their blood sugar levels with less user interaction.

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Insulin Syringes Market size was valued at USD 1.77 Billion in 2023 poised to grow from USD 1.84 Billion in 2024 to USD 2.56 Billion by 2032, growing at a CAGR of 4.20% in the forecast period (2025-2032).

The global insulin syringes market outlook is highly competitive, with key players like Becton Dickinson, Terumo Corporation, Nipro Corporation, and Owen Mumford leading innovation. They concentrate on product differentiation by innovative needle technology, safety and ergonomic designs. Becton Dickinson puts a lot of emphasis on strategic acquisitions and building up its global distributor network, while Terumo heavily invests in the research and development of ultra-thin needles. Collaborative partnerships and compliance with regulations are still key strategies to build market strength globally. 'Becton Dickinson (USA)', 'Terumo Corporation (Japan)', 'Nipro Corporation (Japan)', 'Owen Mumford (UK)', 'Ypsomed Holding AG (Switzerland)', 'Smiths Medical (USA)', 'B. Braun Melsungen AG (Germany)', 'HMD Medical (India)', 'Owen Mumford Ltd (UK)', 'Medline Industries (USA)', 'Shandong Weigao Group Medical Polymer Company (China)', 'Jiangsu Kangjian Medical Equipment Co., Ltd. (China)', 'Lifecare Innovations (India)', 'Owen Mumford Ltd (UK)', 'Henke-Sass, Wolf GmbH (Germany)'

The growing geriatric population globally is at higher risk for diabetes, and therefore, there is increased insulin consumption. With rising cases of age-induced diabetes, demand for insulin syringes increases consistently, propelling market growth owing to the necessity of proper and frequent insulin administration.

Rising Demand for Miniaturized Syringes: There is a tendency towards smaller insulin syringes, i.e., 0.5 ml, providing better dosing accuracy and comfort. This is triggered by higher incidence of pediatric patients and Type 1 diabetics, who urge manufacturers to develop smaller, convenient syringues that increase patient compliance.

How does the Prevalence of Diabetes in North America Impact Syringe Demand?

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Insulin Syringes Market
Insulin Syringes Market

Report ID: SQMIG35B2227

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE